CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target.

Saved in:
Bibliographic Details
Title: CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target.
Authors: Malik S; Kura Oncology, Inc., San Diego, CA 92130, USA., Westcott JM; Division of Surgical Oncology, Department of Surgery, and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Brekken RA; Division of Surgical Oncology, Department of Surgery, and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Burrows FJ; Kura Oncology, Inc., San Diego, CA 92130, USA.
Source: Cancers [Cancers (Basel)] 2021 Dec 24; Vol. 14 (1). Date of Electronic Publication: 2021 Dec 24.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2072-6694
DOI:10.3390/cancers14010086